Shaoxing Tasly Pharmaceutical Co., Ltd. is a landmark enterprise in the modernization of traditional Chinese medicine in China. It was listed on the Shanghai Stock Exchange in August 2002. Shaoxing Tasly Pharmaceutical Co., Ltd. is a leading enterprise in the internationalization of modern Chinese medicine, and is committed to developing into a leading medical and health service institution with global influence in China.
Shaoxing Tasly Pharmaceutical Co., Ltd. has a production workshop that has passed the national and Australian TGA certification and a laboratory that meets the qualification requirements of national laboratory competence accreditation in 2005.